Alvotech Attacks AbbVie Over Adalimumab

Launches US Legal Challenge Over Humira Patent ‘Monopoly’

 
• By David Wallace
Danger Minefield Sign
Alvotech has cited the “minefield of IP” around Humira • Source: Alamy

More from Biosimilars

More from Products